drug

BNT168

1 story · latest Jul 13, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by BioNTech SE

Timeline

BioNTech recruiting for BNT168 HIV vaccine Phase I/II trial

Jul 13Trial updateBioNTech SE BNT168

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.